Marco G. Rovaris

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 133 publications

Gray Matter Damage and Long-Term Disability, Cognitive Outcome, and Survival in Patients With Multiple Sclerosis.

Gray Matter Damage and Long-Term Disability, Cognitive Outcome, and Survival in Patients With Multiple Sclerosis.

Journal: Neurology

Published: July 21, 2026

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 04, 2026

IL-1 polymorphisms modulates functional recovery following rehabilitation in multiple sclerosis.

IL-1 polymorphisms modulates functional recovery following rehabilitation in multiple sclerosis.

Journal: Frontiers in immunology

Published: May 04, 2026

Beyond GLM: Inter-Subject Variability as a Complementary Approach to Detect Longitudinal Changes in Emotion Processing in Multiple Sclerosis.

Beyond GLM: Inter-Subject Variability as a Complementary Approach to Detect Longitudinal Changes in Emotion Processing in Multiple Sclerosis.

Journal: Journal of imaging

Published: April 01, 2026

Efficacy of traditional swallowing therapy plus neuromuscular electrostimulation in multiple sclerosis: A randomized controlled trial.

Efficacy of traditional swallowing therapy plus neuromuscular electrostimulation in multiple sclerosis: A randomized controlled trial.

Journal: Multiple sclerosis and related disorders

Published: December 21, 2025

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

Journal: JAMA network open

Published: November 03, 2025

Serum miR-199a-3p and miR-103a-3p are possible biomarkers for the onset of multiple sclerosis.

Serum miR-199a-3p and miR-103a-3p are possible biomarkers for the onset of multiple sclerosis.

Journal: Scientific reports

Published: September 01, 2025

Sex-Specific Effects of AQP4 Gene Polymorphisms on Multiple Sclerosis Susceptibility and Response to Multidisciplinary Rehabilitation.

Sex-Specific Effects of AQP4 Gene Polymorphisms on Multiple Sclerosis Susceptibility and Response to Multidisciplinary Rehabilitation.

Journal: International journal of molecular sciences

Published: August 06, 2025

Beyond EDSS: multidomain impairments are detectable and associated with walking disorders in low-disabled people with multiple sclerosis.

Beyond EDSS: multidomain impairments are detectable and associated with walking disorders in low-disabled people with multiple sclerosis.

Journal: Journal of neurology

Published: March 13, 2025

Time efficiency in mental state reasoning of people with multiple sclerosis: The double-sided affective and cognitive Theory of Mind disturbances.

Time efficiency in mental state reasoning of people with multiple sclerosis: The double-sided affective and cognitive Theory of Mind disturbances.

Journal: The Clinical neuropsychologist

Published: December 26, 2024

Effects of high-intensity multimodal functional training on motor and cognitive functions in people with multiple sclerosis: A study protocol of a pilot randomized controlled trial.

Effects of high-intensity multimodal functional training on motor and cognitive functions in people with multiple sclerosis: A study protocol of a pilot randomized controlled trial.

Journal: Digital health

Published: December 20, 2024

Delivering the Lee Silverman voice treatment-loud method in-site versus telerehabilitation in people with multiple sclerosis: Feasibility evidence of a non-inferiority pilot randomized controlled trial.

Delivering the Lee Silverman voice treatment-loud method in-site versus telerehabilitation in people with multiple sclerosis: Feasibility evidence of a non-inferiority pilot randomized controlled trial.

Journal: Digital health

Published: November 14, 2024

Showing 1-12 of 133

Last Updated: 09/26/2026